Zymeworks presents IND-enabling data for ZW49, a biparatopic HER2-targeted ADC
09 Dec 2018 //
PHARMABIZ
BeiGene inks $60M licensing, research pacts with Zymeworks
29 Nov 2018 //
ENDPTS
Zymeworks and BeiGene Announce License and Collaboration Agreement
29 Nov 2018 //
BUSINESSWIRE

Market Place
Sourcing Support